LMS Funding Opportunities
New opportunities coming soon!
Developmental Research Project and Career Enhancement Award Winners
2025 LMS SPORE Career Enhancement Program (CEP) Recipients:
Ryan Denu, MD, PhD, MD Anderson Cancer Center
Project: Targeting ATRX-mutant LMS
Balakrishna Koneru, PhD, Texas Tech University
Project: Targeting the Alternative Lengthening of Telomeres Mechanism in Osteosarcoma: Preclinical Evaluation of FANCM Inhibition as a Precision Therapeutic Strategy
2025 LMS SPORE Developmental Research Program (DRP) Recipient:
Brian Van Tine, MD, PhD, WashU Medicine
Project: Modulating Tumor Metabolism and Diet as a Therapy in Osteosarcoma
2024 LMS SPORE Career Enhancement Program (CEP) Recipients:
Candace L. Haddox, M.D., Dana-Farber Cancer Institute
Project: Characterizing biologic mechanisms that determine whether leiomyosarcoma clinical course is indolent vs. typical
Erin E. Resch, M.D., Johns Hopkins University
Project: Combining chemotherapy with STING immunotherapy to improve treatment outcomes in osteosarcoma
2024 LMS SPORE Developmental Research Program (DRP) Recipients:
Emily Zhi-Yun Keung, M.D., A.M., F.A.C.S., MD Anderson Cancer Center
Project: Elucidation of Intratumoral Immune Microenvironment Characteristics of Primary Soft Tissue Sarcomas and Their Matched Regional and Distant Metastases
Marisa R. Nucci, M.D., Brigham & Women’s Hospital
Project: Deep Learning to Optimize Diagnosis & Therapeutic Selection for Uterine Leiomyosarcoma Patients
2023 LMS SPORE Career Enhancement Program (CEP) Recipient:
Josephine K. Dermawan, M.D., Ph.D., Cleveland Clinic
Project: Defining Novel Genomic Risk Stratification Models and Cellular Lineage in Leiomyosarcoma Subtypes
2023 LMS SPORE Developmental Research Program (DRP) Recipient:
Inga-Marie Schaefer, M.D., Brigham and Women’s Hospital
Project: Targeting cell cycle dysregulation in sarcomas with complex karyotypes
2022 LMS SPORE Career Enhancement Program (CEP) Recipient:
Elise F. Nassif, M.D., MD Anderson Cancer Center
Project: Identifying Biomarker-Based Immune Targets in Molecular Subtypes of Leiomyosarcomas
2022 LMS SPORE Developmental Research Program (DRP) Recipients:
Nicolas J. Llosa, M.D., Johns Hopkins Medicine
Project: Immunotherapeutic barriers at the level of the Leiomyosarcoma immune microenvironment
Brittany L. Siontis, M.D., Mayo Clinic
Project: Multi-Omics to Distinguish Leiomyosarcoma Subtypes
Referencing the LMS SPORE Grant
Each publication, press release, or other document about research supported by an NIH award must include an acknowledgment of NIH award support and a disclaimer such as:
Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number P50CA272170. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
